FDA Generic Drug Rejection, Approval Rates Tell a Conflicting Story.

The article discusses the U.S. Food and Drug Administration's (FDA) guidance on the Generic Drug User Fee Act (GDUFA) of 2012. Topics covered include the GDUFA requiring genetic industry stakeholders to pay user fees to supplement the costs associated with reviewing generic drug applications and the faster inspection of facilities.